These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6462522)

  • 1. [Endoperitoneal radioisotope therapy of malignant epithelial tumors of the ovary].
    Tardy A; Boidi-Trotti A
    Minerva Ginecol; 1984 Apr; 36(4):199-201. PubMed ID: 6462522
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of P-32 in stage III epithelial carcinoma of the ovary.
    Spanos WJ; Day T; Jose B; Paris K; Lindberg RD
    Gynecol Oncol; 1994 Jul; 54(1):35-9. PubMed ID: 8020836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter: Loculation as a contraindication to intracavitary 32P-chromic phosphate therapy.
    Vider M; Deland FH; Maruyama Y
    J Nucl Med; 1976 Feb; 17(02):150-1. PubMed ID: 1245879
    [No Abstract]   [Full Text] [Related]  

  • 4. [The significance of dosimetry in monitoring radiogold after intraperitoneal administration].
    Dvorák O; Slavík V; Prokes K; Bechynĕ M
    Cesk Gynekol; 1982 Sep; 47(8):587-9. PubMed ID: 7139747
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intraperitoneal irradiation in limited epithelial neoplasms of the ovary. Review of the literature].
    Wolff JP; Burini GA
    Minerva Ginecol; 1985; 37(7-8):407-13. PubMed ID: 3906441
    [No Abstract]   [Full Text] [Related]  

  • 6. Radioactive phosphorus and external radiation as an adjuvant to surgery for ovarian carcinoma.
    Julian CG; Inalsingh CH; Burnett LS
    Obstet Gynecol; 1978 Aug; 52(2):155-60. PubMed ID: 683654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radionuclide therapy of malignant tumors].
    Altenbrunn HJ
    Z Gesamte Inn Med; 1978 Jul; 33(14):475-84. PubMed ID: 581247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of the intraperitoneal application of radioactive gold in cases of ovarian cancer (author's transl)].
    Möhlen KH; Quakernack K; Beller FK
    Geburtshilfe Frauenheilkd; 1978 Dec; 38(12):1075-8. PubMed ID: 730023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transcutaneous radiotherapy of malignant epithelial tumors of the ovary].
    Boidi-Trotti A; Tardy A
    Minerva Ginecol; 1984 Apr; 36(4):203-4. PubMed ID: 6462523
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of radioisotopes as adjunct therapy of localized ovarian cancer.
    Buchsbaum HJ; Keetel WC; Latourette HB
    Semin Oncol; 1975 Sep; 2(3):247-51. PubMed ID: 1234805
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of ovarian cancer without ascites, using radioactivesuspensions; Study of results analyzed by computer].
    Clode WH; Rodrigues E; Nogueira AR; Baptista AM
    Arq Patol; 1974 Apr; 46(1):89-96. PubMed ID: 4462525
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiotherapy in early ovarian cancer.
    Thomas GM
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S73-9. PubMed ID: 7835813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioisotopes in the treatment of ovarian cancer.
    Rosenshein NB
    Clin Obstet Gynaecol; 1983 Aug; 10(2):279-95. PubMed ID: 6617040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Postoperative X-ray therapy in epithelial ovarian carcinoma].
    Kogelnik HD; Szepesi T
    Gynakol Rundsch; 1982; 22(2):88-95. PubMed ID: 7106627
    [No Abstract]   [Full Text] [Related]  

  • 15. Intracavitary use of radioactive colloidal phosphorus 32 in the treatment of epithelial ovarian cancer.
    Saul HM; Sedlacek TV; Heller PB; Glassburn JR; Riva J; Bertoli R; Maslack M; Lin JK
    J Am Osteopath Assoc; 1996 Dec; 96(12):727-32. PubMed ID: 9111774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant epithelial ovarian tumors].
    Lacroze M
    Soins; 1995 Oct; (599):26-30. PubMed ID: 8701350
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiocolloids in the treatment of ovarian cancer.
    Rosenshein NB; Leichner PK; Vogelsang G
    Obstet Gynecol Surv; 1979 Sep; 34(9):708-20. PubMed ID: 386194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal chromic phosphate in ovarian cancer: risks and benefits.
    Potter ME; Partridge EE; Shingleton HM; Soong SJ; Kim RY; Hatch KD; Austin JM
    Gynecol Oncol; 1989 Mar; 32(3):314-8. PubMed ID: 2920951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To P32 or not to P32, that is the question.
    Runowicz CD
    Gynecol Oncol; 1993 Aug; 50(2):139-40. PubMed ID: 8375726
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic intraperitoneal 32P: a clinical assessment of the dynamics of distribution.
    Kaplan WD; Zimmerman RE; Bloomer WD; Knapp RC; Adelstein SJ
    Radiology; 1981 Mar; 138(3):683-8. PubMed ID: 7465847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.